Tumor Site and Perigastric Nodal Status are the Most Important Predictors of Para-Aortic Nodal Involvement in Advanced Gastric Cancer

被引:20
作者
de Manzoni, Giovanni [1 ]
Di Leo, Alberto [4 ]
Roviello, Franco [2 ]
Marrelli, Daniele [2 ]
Giacopuzzi, Simone [1 ]
Minicozzi, Anna Maria [1 ]
Verlato, Giuseppe [3 ]
机构
[1] Univ Verona, Div Gen Surg 1, I-37100 Verona, Italy
[2] Univ Verona, Div Surg Oncol, I-37100 Verona, Italy
[3] Univ Verona, Unit Epidemiol & Med Stat, I-37100 Verona, Italy
[4] APSS Trento, Arco Hosp, Unit Gen Surg, Trento, Italy
关键词
EXTENDED D2; DISSECTION; LYMPHADENECTOMY; D3; COMPLICATIONS; METASTASIS; MORTALITY; TRIAL; TREND; D4;
D O I
10.1245/s10434-010-1547-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study was designed to identify pathological predictors of para-aortic nodal invasion in advanced gastric cancer. Between 1990 and 2007, 294 patients with advanced gastric cancer underwent gastrectomy with D2 lymphadenectomy + para-aortic nodal dissection in Siena and Verona, Italy. Forty-seven (16%) patients had para-aortic node metastases. Of these, 91%, 88%, and 74%, respectively, also had metastases at stations No. 3, No. 1, and No. 7. Para-aortic node metastases were never observed when stations No. 1 and No. 3 were both negative. Patients were divided into three groups, according to the risk of para-aortic node invasion: (1) high-risk group (n = 24, 8.2%), presenting a 42% risk and comprising T3/T4 cancers with mixed/nonintestinal histology, arising from the upper third; (2) low-risk group (n = 138, 46.9%), presenting a 0-10% risk and including middle-lower third tumors-either T2 irrespective of histology, or T3/T4 with intestinal histology; (3) intermediate-risk group, comprising all other patients (n = 132, 44.9%). Their risk ranged between 16% and 30%, but increased up to 21-37.5% after excluding 33 patients with negative No. 1 and No. 3 stations. The combination of tumor site, histology, and T stage with perigastric nodal status allowed identification of patients at higher risk of para-aortic nodal invasion who could benefit from para-aortic nodal dissection.
引用
收藏
页码:2273 / 2280
页数:8
相关论文
共 23 条
  • [1] Bostanci EB, 2004, EUR J SURG ONCOL, V30, P20, DOI 10.1016/j.ejso.2003.10.008
  • [2] DEMANZONI G, 1996, BRIT J SURG, V83, P1064
  • [3] Lymph node involvement in gastric cancer for different tumor sites and T stage
    Di Leo, Alberto
    Marrelli, Daniele
    Roviello, Franco
    Bernini, Marco
    Minicozzi, AnnaMaria
    Giacopuzzi, Simone
    Pedrazzani, Corrado
    Baiocchi, Luca Gian
    de Manzoni, Giovanni
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2007, 11 (09) : 1146 - 1153
  • [4] Gunji Y, 2003, HEPATO-GASTROENTEROL, V50, P1178
  • [5] Günther K, 2000, SURG TODAY, V30, P700
  • [6] Hansen S, 1997, INT J CANCER, V71, P340, DOI 10.1002/(SICI)1097-0215(19970502)71:3<340::AID-IJC5>3.0.CO
  • [7] 2-Y
  • [8] Japanese Gastric Cancer Association, 1998, Gastric Cancer, V1, P10
  • [9] Para-aortic lymph node dissection revisited: Have we been neglecting a promising treatment option for gastric carcinoma?
    Kodera, Y.
    [J]. EJSO, 2010, 36 (05): : 447 - 448
  • [10] Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial
    Kulig, Jan
    Popiela, Tadeusz
    Kolodziejczyk, Piotr
    Sierzega, Marek
    Szczepanik, Antoni
    [J]. AMERICAN JOURNAL OF SURGERY, 2007, 193 (01) : 10 - 15